vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Brookfield Asset Management Ltd. (BAM). Click either name above to swap in a different company.
Brookfield Asset Management Ltd. is the larger business by last-quarter revenue ($1.1B vs $950.5M, roughly 1.1× Astrana Health, Inc.). Brookfield Asset Management Ltd. runs the higher net margin — 56.7% vs 0.7%, a 56.0% gap on every dollar of revenue.
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Brookfield Asset Management Ltd. is a Canadian-American alternative asset manager. The company was founded in December 2022 as a spin-off of the asset management operations of Brookfield Corporation, and manages investments across real estate, infrastructure, renewable energy, private equity, and credit markets globally.
ASTH vs BAM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.1B |
| Net Profit | $6.6M | $615.0M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | 84.2% |
| Net Margin | 0.7% | 56.7% |
| Revenue YoY | 42.9% | — |
| Net Profit YoY | 184.4% | — |
| EPS (diluted) | $0.12 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.1B | ||
| Q3 25 | $956.0M | $974.0M | ||
| Q2 25 | $654.8M | $931.0M | ||
| Q1 25 | $620.4M | $954.0M | ||
| Q4 24 | $665.2M | — | ||
| Q3 24 | $478.7M | $873.0M | ||
| Q2 24 | $486.3M | $821.0M | ||
| Q1 24 | $404.4M | $786.0M |
| Q4 25 | $6.6M | $615.0M | ||
| Q3 25 | $373.0K | $692.0M | ||
| Q2 25 | $9.4M | $584.0M | ||
| Q1 25 | $6.7M | $507.0M | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | $16.1M | $537.0M | ||
| Q2 24 | $19.2M | $124.0M | ||
| Q1 24 | $14.8M | $373.0M |
| Q4 25 | 1.9% | 84.2% | ||
| Q3 25 | 2.0% | 79.1% | ||
| Q2 25 | 3.1% | 70.8% | ||
| Q1 25 | 3.3% | 61.0% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.9% | 72.5% | ||
| Q2 24 | 6.2% | 80.4% | ||
| Q1 24 | 7.5% | 56.5% |
| Q4 25 | 0.7% | 56.7% | ||
| Q3 25 | 0.0% | 71.0% | ||
| Q2 25 | 1.4% | 62.7% | ||
| Q1 25 | 1.1% | 53.1% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 3.4% | 61.5% | ||
| Q2 24 | 3.9% | 15.1% | ||
| Q1 24 | 3.7% | 47.5% |
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.19 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.33 | — | ||
| Q2 24 | $0.40 | — | ||
| Q1 24 | $0.31 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $1.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $8.9B |
| Total Assets | $2.2B | $17.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $1.6B | ||
| Q3 25 | $463.4M | $1.1B | ||
| Q2 25 | $342.1M | $480.0M | ||
| Q1 25 | $260.9M | $332.0M | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | $10.0M | ||
| Q1 24 | $337.3M | — |
| Q4 25 | $779.3M | $8.9B | ||
| Q3 25 | $775.5M | $8.5B | ||
| Q2 25 | $765.5M | $8.5B | ||
| Q1 25 | $745.4M | $8.5B | ||
| Q4 24 | $712.7M | — | ||
| Q3 24 | $704.6M | $9.0B | ||
| Q2 24 | $678.9M | $3.2B | ||
| Q1 24 | $653.5M | $2.2B |
| Q4 25 | $2.2B | $17.0B | ||
| Q3 25 | $2.2B | $16.5B | ||
| Q2 25 | $1.4B | $16.1B | ||
| Q1 25 | $1.3B | $15.0B | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | $4.2B | ||
| Q1 24 | $1.2B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $562.0M |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | 0.91× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $562.0M | ||
| Q3 25 | $10.0M | $745.0M | ||
| Q2 25 | $90.9M | $529.0M | ||
| Q1 25 | $16.6M | $265.0M | ||
| Q4 24 | $-10.9M | — | ||
| Q3 24 | $34.0M | $567.0M | ||
| Q2 24 | $23.2M | $159.0M | ||
| Q1 24 | $6.0M | $516.0M |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | -0.44× | 0.91× | ||
| Q3 25 | 26.69× | 1.08× | ||
| Q2 25 | 9.65× | 0.91× | ||
| Q1 25 | 2.48× | 0.52× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 1.06× | ||
| Q2 24 | 1.21× | 1.28× | ||
| Q1 24 | 0.40× | 1.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BAM
| Incentive Fees | $452.0M | 42% |
| Infrastruture | $332.0M | 31% |
| Private Equity | $174.0M | 16% |
| Renewable Power And Transition | $66.0M | 6% |
| Other | $47.0M | 4% |
| Management And Advisory Fees | $14.0M | 1% |
